OptionsHouse

Options Trading News

April 18, 2013  Thu 7:32 AM CT

THRX: SEE CHART GET CHAIN FIND STRATEGIES
Respiratory Drug Closer to Approval

Theravance announced that a Food & Drug Administration panel voted in favor of approving its BREO Ellipta respiratory drug. THRX is up 15 percent before the bell on my tradeMONSTER platform.

Select Comfort Earnings, Revenue Miss

Select Comfort reported first-quarter earnings of $0.41 a share, missing the $0.43 average analyst estimate. Revenue of $258.2 million also missed the $288 million consensus number, and management cut full-year profit guidance. SCSS drops 3 percent in early trading.

Weak Sales Hurt eBay

EBay's earnings beat by a penny, but revenue was just $3.75 billion. Analysts had forecast $3.77 billion. Guidance was also lower than expected, and EBAY is down 3.5 percent in the premarket.
Share this article with your friends


OptionsHouse

Premium Services

Education & Strategy

Market Level Making You Nervous, Huh? Part 3

In last week's article, we discussed how important the extra cash you save by using the Stock Replacement Strategy over buying the actual stock is! That extra cash in our account instead of being unnecessarily tied up in a stock position allows us to buy the puts we would need to protect our downside in the case of a major sell-off.

View more education articles »